Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases

Journal of Rheumatology

Volumn 32, Issue 5, 2005, Pages 863-869

  Kumagai, Shunichi ^a   Kawano, Seiji ^a   Atsumi, Tatsuya ^b   Inokuma, Shigeko ^c   Okada, Yosuke ^d   Kanai, Yoshiki ^e   Kaburaki, Junichi ^f   Kameda, Hideto ^g   Suwa, Akira ^h   Hagiyama, Hiroyuki ⁱ   Hirohata, Shunsei ^j   Marino, Hirofumi ^k   Hashimoto, Hiroshi ^e  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO ELECTRIC POWER COMPANY   (Japan)

^g SAITAMA MEDICAL CENTER   (Japan)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^j TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k OKAYAMA UNIVERSITY   (Japan)

more..

Author keywords

Bone mineral density; Glucocorticoid; Hyperlipidemia; Menopause; Osteoporosis; Vertebral fracture

Indexed keywords

CHOLESTEROL; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BONE DENSITY; CHI SQUARE DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; VERTEBRA FRACTURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERLIPIDEMIAS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS; ROC CURVE; SPINAL FRACTURES;

EID: 21044436876     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002;13:777-87.
2. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54:49-52.
3. Hooyman JR, Melton LJ 3rd, Nelson AM, O'Fallon M, Riggs BL. Fractures after rheumatoid arthritis. Arthritis Rheum 1984;27:1353-61.
4. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
5. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Fractures and oral corticosteroids: relationship to daily and cumulative dose. Rheumatology Oxford 2000;39:1383-9.
6. Walsh LJ, Wong CA, Oborne J, et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001;56:279-84.
7. Dykman TR, Gluck O, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361-8.
8. Canalis E. Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid induced osteoporosis. J Clin Endocrinol Metab 1996;81:3441-7.
9. Sambrook P, Lane NE. Corticosteroid osteoporosis. Best Pract Res Clin Rheumatol 2001;15:401-13.
10. Manolagas SC. Corticosteroids and fractures: a close encounter of the third cell kind [editorial]. J Bone Miner Res 2000;15:1001-5.
11. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 2003;38:3224-9.
12. Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991;46:803-6.
13. Genant HK, Grampp S, Gluer CC, et al. Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 1994;9:1316-7.
14. Orimo H, Sugioka Y, Fukunaga M, et al. Diagnostic criteria of primary osteoporosis. The Committee of the Japanese Society for Bone and Mineral Research for Development of Diagnostic Criteria of Osteoporosis. J Bone Miner Metab 1998;16:139-50.
15. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5-20.
17. Hata Y, Mabuchi H, Saito Y, et al. Report of the Japan Atherosclerosis Society guidelines for diagnosis and treatment of hyperlipidemia in Japanese adults. J Atheroscler Thromb 2002;9:1-27.
18. Nakayamada S, Ukada Y, Saito K, Tanaka Y. Etidronate prevents high-dose glucocorticoid-induced bone loss in premenopausal individuals with systemic autoimmune diseases. J Rheumatol 2004;31:163-6.
19. Selby PL, Halsey JP, Adams KRH, et al. Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 2000;15:952-6.
20. Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook PN. Vertebral fracture risk with long-term corticosteroid therapy. Arch Intern Med 2000;160:2917-22.
21. Peel NFA, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54:801-6.
22. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2001;44:1496-503.
23. Bone and Tooth Society of Great Britain, Royal College of Physicians, and National Osteoporosis Society. Guidelines on the prevention and treatment of glucocorticoid-induced osteoporosis. London: Royal College of Physicians; 2003.
24. Adachi JD, Olszynski WP, Hanley DA, et al. Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum 2000;29:228-51.
25. Johnell O, de Laet C, Johansson H, et al. Oral corticosteroids increase fracture risk independently of BMD [abstract]. Osteoporosis Int 2002;13 Suppl 1:S14.
26. Weinstein RS, Jilka RL, Parfitt M, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82.
27. Parhami F, Demer LL. Arterial calcification in face of osteoporosis in ageing: can we blame oxidized lipids? Curr Opin Lipidol 1997;8:312-4.
28. Parhami F, Jackson SM, Tintut Y, et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stroma cells. J Bone Miner Res 1999;14:2067-78.